M. C. Buncke, M. Diamant, A. Corner, B. Eliasson, J. L. Malloy, R. M. Shaginian, et al., “One-Year Treatment with Exenatide Improves Beta-Cell Function, Insulin Compare with Glargine, in Metformin-Treat Type 2 Diabetic Patients: A Randomized, Controlled Trial,” Diabetes Care, Vol. 32, No. 5, 2009, pp. 762-768.
 M. E. Tushuizen, C. M. Buncke, P. J. Pouwels, J. H. van Waesberghe, M. Diamant and R. J. Heine, “Incretinmimetics as a Novel Option for Hepatic Steatosis Therapeutic,” Liver Internatioanl, Vol. 26, No. 8, 2006, pp. 1015-1017.
 T. D. Adams, R. E. Gress, S. C. Smith, et al., “Long-Term Mortality after Gastric Bypass Surgery,” The New England Journal of Medicine, Vol. 357, No. 8, 2007, pp. 753-761. http://dx.doi.org/10.1056/NEJMoa066603
 R. Nandagopal, R. J. Brown and K. I. Rother, “Resolution of Type 2 Diabetes Following Bariatric Surgery: Implications for Adults and Adolescents,” Diabetes Technology & Therapeutics, Vol. 12, No. 8, 2010, pp. 671-677.
 D. G. Parkes, R. Pittner, C. Jodka, et al., “Insulinotropic Actions of Exendin-4 and Glucagon-Like Peptide 1 in Vivo and in Vitro,” Metabolism, Vol. 50, No. 5, 2001, pp. 583-589. http://dx.doi.org/10.1053/meta.2001.22519
 K. G. Alberti, P. Zimmet and J. Shaw, “Metabolic Syndrome—A New Worldwide Definition. A Consensus Statement from the International. Diabetes Federation,” Diabetic Medicine, Vol. 23, No. 5, 2006, pp. 469-480.
 G. S. Berenson, S. R. Srinivasan, W. Bao, W. P. Newman 3rd, R. E. Tracy and W. A. Wattigney, “Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults. The Bogalusa Heart Study,” The New England Journal of Medicine, Vol. 338, No. 23, 1998, pp. 1650-1656.
 N. M. McGrath, G. N. Parker and P. Dawson, “Early Presentation of Type 2 Diabetes Mellitus in Young New Zealand Maori,” Diabetes Research and Clinical Practice, Vol. 43, No. 3, 1999, pp. 205-209.
 A. Fleischman and E. T. Rhodes, “Management of Obesity, Insulin Resistance and Type 2 Diabetes in Children: Consensus and Controversy,” Diabetes, Metabolic Syndrome and Obesity, Vol. 2, 2009, pp. 185-202.
 M. C. Riddle, R. R. Henry, T. H. Poon, et al., “Exenatide Elicits Sustained Glycemic Reduction and Control of Body Weight Progressive in Patients with Type 2 Diabetes Inadequately Controlled by Sulphonylureas with or without Metformin,” Diabetes/Metabolism Research and Reviews, Vol. 22, No. 6, 2006, pp. 483-491.